This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Post-transplant treatment
Consolidation and maintenance therapy after ASCT can provide sustained disease control and prevent repeated relapses
Consolidation therapy
- Short period of intensive treatment with a single agent or combination of agents
- Often evaluated in clinical trials
- May improve the depth of response and outcomes
Maintenance therapy
- Long term use of low-dose therapy
- Eliminates residual malignant cells after ASCT and delay progression of disease
- Shown to improve progression-free survival and overall survival
ASCT, autologous stem cell transplant.
1. Krishnan A, et al. Am Soc Clin Oncol Educ Book. 2016;36:210-221. 2. Koniarczyk HL, et al. Semin Oncol Nurs. 2017;33(3):265-278.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.